Status:
COMPLETED
Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells
Lead Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Conditions:
Stress Urinary Incontinence
Eligibility:
FEMALE
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Treatment of women with stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen gel
Detailed Description
During the implementation of the project, method for the treatment of women stress urinary incontinence using injection of autologous adipose-derived mesenchymal stem cells mixed with collagen was dev...
Eligibility Criteria
Inclusion
- Stress urinary incontinence
- absence of acute inflammatory manifestations in the genitourinary system
Exclusion
- urethral or bladder malformations
- acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
- mental disorders
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04446884
Start Date
March 1 2018
End Date
December 31 2019
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hrodna City Clinical Hospital
Hrodna, Belarus, 230009